Institutions & companies

Roche

Medicine & Biotech · covered by 9 outlets this week · tracked since 2026-10-27

Press: 3 mainstream 7 specialist outlet-days

Coverage

study

STAT+: Roche gets a lung cancer win with its KRAS drug divarasib

STAT News · 1d ago

ESMO ‘26: A cancer vaccine debate, Roche’s KRAS progress and Amgen’s ‘unprecedented’ data

BioPharma Dive · 1d ago

study

STAT+: Pharmalittle: We’re reading about a Roche lung cancer drug, a Bristol CAR-T trial death, and more

STAT News · 1d ago

Roche Targets Emerging Oncology Market With New Lung-Cancer Drug

WSJ Health · 2d ago

study

Lycia Lands a $317M IPO for Inflammation Drugs Based on Nobel Prize-Winning Science

MedCity News · 2d ago

STAT+: Novartis multiple sclerosis treatment cuts rates of relapse in pivotal trials

STAT Biotech · 4d ago

Roche CEO Signals New Wave of Drugs to Fuel Growth Next Year, Beyond

WSJ Health · 5d ago

Roche licenses Rona’s RNAi drug that targets fat cells

Longevity.Technology · 6d ago

Roche Partners With China’s Hansoh in Deal That Could Top $15 Billion

WSJ Health · 8d ago

Rona Therapeutics licenses selective fat-loss RNAi drug to Roche in $1.1b deal

Longevity.Technology · 12d ago

ProMIS appoints new chief commercial officer to prepare Alzheimer’s drug PMN310 for market

Longevity.Technology · 19d ago